相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System
Holly C. May et al.
FRONTIERS IN MICROBIOLOGY (2018)
Phenylthiazole Antibacterial Agents Targeting Cell Wall Synthesis Exhibit Potent Activity in Vitro and in Vivo against Vancomycin-Resistant Enterococci
Haroon Mohammad et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial
Jonathan Kil et al.
LANCET (2017)
A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
Mohamed F. Mohamed et al.
SCIENTIFIC REPORTS (2017)
In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens
Waleed Younis et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate
Mohamed F. Mohamed et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Tigecycline resistance in clinical isolates of Enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M)
S. Fiedler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis
Tomas N. Gustafsson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus
Huy X. Ngo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Drug Repurposing for the Treatment of Staphylococcal Infections
Shankar Thangamani et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections
Waleed Younis et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
A small-molecule antivirulence agent for treating Clostridium difficile infection
Kristina Oresic Bender et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Repurposing celecoxib as a topical antimicrobial agent
Shankar Thangamani et al.
FRONTIERS IN MICROBIOLOGY (2015)
Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant Staphylococci
Haroon Mohammad et al.
JOURNAL OF ANTIBIOTICS (2015)
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
Shankar Thangamani et al.
PLOS ONE (2015)
Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections
Shankar Thangamani et al.
SCIENTIFIC REPORTS (2015)
Linezolid Resistance in Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolates in a Brazilian Hospital
Lara M. de Almeida et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Targeting Methicillin-Resistant Staphylococcus aureus with Short Salt-Resistant Synthetic Peptides
Mohamed F. Mohamed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature
Vincent C. C. Cheng et al.
BMC INFECTIOUS DISEASES (2014)
Mechanisms of antibiotic resistance in enterococci
William R. Miller et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways
Gajendra Kumar Azad et al.
MOLECULAR BIOLOGY REPORTS (2014)
Multistate Point- Prevalence Survey of Health Care- Associated Infections
Shelley S. Magill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A safe lithium mimetic for bipolar disorder
Nisha Singh et al.
NATURE COMMUNICATIONS (2013)
Intrinsic and acquired resistance mechanisms in enterococcus
Brian L. Hollenbeck et al.
VIRULENCE (2012)
Emergence of Daptomycin-Resistant VRE: Experience of a Single Institution
Mini Kamboj et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
Management of multidrug-resistant enterococcal infections
C. A. Arias et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Antiatherosclerotic and Renoprotective Effects of Ebselen in the Diabetic Apolipoprotein E/GPx1-Double Knockout Mouse
Phyllis Chew et al.
DIABETES (2010)
Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans
Caries Ubeda et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Synthesis and bacterial biofilm inhibition studies of ethyl N-(2-phenethyl) carbamate derivatives
Steven A. Rogers et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2010)
Ebselen treatment reduces noise induced hearing loss via the mimicry and induction of glutathione peroxidase
Jonathan Kil et al.
HEARING RESEARCH (2007)
Quinupristin-dalfopristin resistance in Enterococcus faecium isolates from humans, farm animals, and grocery store meat in the United States
S. M. Donabedian et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Enterococcal colonization of the gastro-intestinal tract: role of biofilm and environmental oligosaccharides
Roberta Creti et al.
BMC MICROBIOLOGY (2006)
High rate of resistance to quinupristin-dalfopristin in Enterococcus faecium clinical isolates from Korea
WS Oh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Efficacy of oral ramoplanin for inhibition of intestinal colonization by vancomycin-resistant enterococci in mice
U Stiefel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Nosocomial spread of linezolid-resistant, vancomycin-resistant enterococcus faecium
IA Herrero et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.
CJ Donskey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Vancomycin-resistant enterococci
Y Cetinkaya et al.
CLINICAL MICROBIOLOGY REVIEWS (2000)
分享论文
